Table 1 Individual patient information on demographics, histology, gene, and outcomes.

From: Pleomorphic xanthoastrocytomas of adults: MRI features, molecular markers, and clinical outcomes

Variable Number (n = 50)
Median age (years) 36 (18–67)
Gender
  Male 31 (62%)
  Female 19 (38%)
Symptoms
  Seizures 15 (30%)
  Headaches 24 (48%)
  Focal neurological deficits 13 (26%)
  Visual disturbances 11 (22%)
Extent of surgery
  Gross total resection 37 (74%)
  Subtotal resection 10 (20%)
  Partial resection 3 (6%)
Histopathology
  Grade II PXA 26 (52%)
  Grade III anaplastic PXA 24 (48%)
BRAF V600E status
  Mutated 12 (41%)
  Non-V600E mutated 17 (59%)
  N/A 21
IDH1 status
  Mutated 1 (3%)
  Non-mutated 35 (97%)
  N/A 14
IDH2 status
  Mutated 0
  Non-mutated 36 (100%)
  N/A 14
Clinical outcomes
  Complete remission 16 (53%)
  Recurrence or progression 14 (47%)
  N/A 20
  1. N/A = not available.